打开APP

金纳米颗粒首次被用来输送RNA治疗脑瘤

  1. RNA
  2. 脑瘤
  3. 金纳米颗粒

来源:生物谷 2013-11-12 09:01

2013年11月11日讯 /生物谷BIOON/ --西北大学研究人员首次利用金纳米颗粒来输送RNA以治疗多形性成胶质细胞瘤,这种脑瘤被认为是最难以治愈的癌症之一。研究人员将一种名为球型核苷酸(SNA)的干扰RNA通过金纳米颗粒导入到病灶部位,阻断基因Bcl2Like12的表达,这种基因在脑瘤患者中为高表达状态。

这一研究成果被发表在Science Translational Medicine上,研究人员希望据此开发出一种治疗多形性胶质细胞瘤的有效疗法。(生物谷Bioon.com)

详细英文报道:

To deliver a genetic kill switch to a particularly aggressive brain tumor, researchers at Northwestern University are turning to gold nanoparticles designed to maneuver their way into the cancer cells.

The team has developed a technique to deliver RNA-based drugs to glioblastoma multiforme, a highly aggressive and difficult-to-treat brain tumor that is currently considered incurable. The Northwestern researchers are the first to show that this delivery is possible, according to a report from the university.

The genetic component of the drug is a slightly different type of interfering RNA called spherical nucleic acids (SNA), invented at Northwestern in 1996, that are nontoxic to humans, as opposed to many other cancer treatments. The SNA knocks down the gene Bcl2Like12, which is abundant in glioblastoma tumors and often allows for its resistance to drugs.

And the delivery method is unique: The nanoparticle has a spherical shape that allows it to maneuver into the cancer cells. And by densely packing the nucleic acids onto the gold's surface, the genetic material can enter the cell by hitching a ride with the delivery vehicle. The team published the study in the journal Science Translational Medicine.

"This is a beautiful marriage of a new technology with the genes of a terrible disease," said Northwestern study author Chad Mirkin. "Using highly adaptable spherical nucleic acids, we specifically targeted a gene associated with GBM and turned it off in vivo. This proof-of-concept further establishes a broad platform for treating a wide range of diseases, from lung and colon cancers to rheumatoid arthritis and psoriasis."

And as for the ambitious project that brought several labs together to develop the technology, Mirkin added: "The problems posed by glioblastoma and many other diseases are simply too big for one research group to handle. This work highlights the power of scientists and engineers from different fields coming together to address a difficult medical issue."

The team next plans to bring the technique into clinical trials.

 

版权声明 本网站所有注明“来源:生物谷”或“来源:bioon”的文字、图片和音视频资料,版权均属于生物谷网站所有。非经授权,任何媒体、网站或个人不得转载,否则将追究法律责任。取得书面授权转载时,须注明“来源:生物谷”。其它来源的文章系转载文章,本网所有转载文章系出于传递更多信息之目的,转载内容不代表本站立场。不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。

87%用户都在用生物谷APP 随时阅读、评论、分享交流 请扫描二维码下载->